All News

Venture capitalists are once again taking a shine to Cleantech, emboldened by the highly successful IPO of a battery company and huge amounts of stimulus funding.

The central priority of the EU’s new Innovation Policy should be utilising research “rapidly and powerfully” for societal and development benefit, say business leaders in a new report.

Two Framework Programme 6 (FP6) schemes specifically devised to promote the development of the European Research Area failed to deliver, according to a new report.

Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.

The commercial imperative is undermining basic research and threatening the university ethos according to an independent body, says a new report.

The European Commission’s probe into suspected anti-trust activity in the pharmaceutical sector is rumbling on, with further dawn raids earlier this week.